Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

New effective scar treatments are urgently needed due to the current options' limited success.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Polarized microscopy is a quick and free method to correctly identify types of hair loss.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.